Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab

Gaia Meoni, Veronica Ghini, Laura Maggi, Alessia Vignoli, Alessio Mazzoni, Lorenzo Salvati, Manuela Capone, Anna Vanni, Leonardo Tenori, Paolo Fontanari, Federico Lavorini, Adriano Peris, Alessandro Bartoloni, Francesco Liotta, Lorenzo Cosmi, Claudio Luchinat, Francesco Annunziato, Paola Turano
doi: https://doi.org/10.1101/2020.11.10.20228361
Gaia Meoni
aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
bGiotto Biotech srl, 50019, Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Ghini
aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
cConsorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (CIRMMP), University of Florence, 50019, Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Maggi
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessia Vignoli
aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
cConsorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (CIRMMP), University of Florence, 50019, Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessio Mazzoni
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Salvati
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Capone
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Vanni
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Tenori
aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
eDepartment of Chemistry “Ugo Schiff”, University of Florence,50019 Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Fontanari
fCardiac Anaesthesia and Intensive Care Unit, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Lavorini
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
gPneumology and Intensive Care Unit, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriano Peris
hIntensive Care Unit and Regional ECMO Referral Centre, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Bartoloni
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
iInfectious and Tropical Diseases Unit, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Liotta
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
jImmunology and Cell Therapy Unit, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Cosmi
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
jImmunology and Cell Therapy Unit, Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Luchinat
aMagnetic Resonance Center (CERM), University of Florence, 50019, Sesto Fiorentino, FI, Italy
eDepartment of Chemistry “Ugo Schiff”, University of Florence,50019 Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Annunziato
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
kFlow Cytometry Diagnostic Center and Immunoterapy (CDCI), Careggi University Hospital, 50134, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: turano@cerm.unifi.it francesco.annunziato@unifi.it
Paola Turano
dDepartment of Clinical and Experimental Medicine, University of Florence, 50134, FI, Italy
eDepartment of Chemistry “Ugo Schiff”, University of Florence,50019 Sesto Fiorentino, FI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: turano@cerm.unifi.it francesco.annunziato@unifi.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The current pandemic emergence of novel coronavirus disease (COVID-19) poses a relevant threat to global health. SARS-CoV-2 infection is characterized by a wide range of clinical manifestations, ranging from absence of symptoms to severe forms that need intensive care treatment. Here, plasma-EDTA samples of 30 patients compared with age- and sex-matched controls were analyzed via untargeted nuclear magnetic resonance (NMR)-based metabolomics and lipidomics. With the same approach, the effect of tocilizumab administration was evaluated in a subset of patients. Despite the heterogeneity of the clinical symptoms, COVID-19 patients are characterized by common plasma metabolomic and lipidomic signatures (91.7% and 87.5% accuracy, respectively, when compared to controls). Tocilizumab treatment resulted in at least partial reversion of the metabolic alterations due to SARS-CoV-2 infection. In conclusion, NMR-based metabolomic and lipidomic profiling provides novel insights into the pathophysiological mechanism of human response to SARS-CoV-2 infection and to monitor treatment outcomes.

Author summary The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is markedly affecting the world population. Here we report about the small-molecule profile of patients hospitalized during the first wave of the COVID-19 pandemic. Using magnetic resonance spectroscopy, we showed that the infection induces profound changes in the metabolome. The analysis of the specific metabolite changes and correlations with clinical data enabled the identification of potential biochemical determinants of the disease fingerprint. We also followed how metabolic alterations revert towards those of the control group upon treatment with tocilizumab, a recombinant humanised monoclonal antibody against the interleukin-6 receptor. These results open up possibilities for the monitoring of novel patients and their individual response to treatment.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Unfunded study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Comitato Etico Regionale-sezione area vasta centro (protocol 16859) and it complies with the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from recruited patients.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the NMR files will be available from the MetaboLights database after publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Gaia Meoni, Veronica Ghini, Laura Maggi, Alessia Vignoli, Alessio Mazzoni, Lorenzo Salvati, Manuela Capone, Anna Vanni, Leonardo Tenori, Paolo Fontanari, Federico Lavorini, Adriano Peris, Alessandro Bartoloni, Francesco Liotta, Lorenzo Cosmi, Claudio Luchinat, Francesco Annunziato, Paola Turano
medRxiv 2020.11.10.20228361; doi: https://doi.org/10.1101/2020.11.10.20228361
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Gaia Meoni, Veronica Ghini, Laura Maggi, Alessia Vignoli, Alessio Mazzoni, Lorenzo Salvati, Manuela Capone, Anna Vanni, Leonardo Tenori, Paolo Fontanari, Federico Lavorini, Adriano Peris, Alessandro Bartoloni, Francesco Liotta, Lorenzo Cosmi, Claudio Luchinat, Francesco Annunziato, Paola Turano
medRxiv 2020.11.10.20228361; doi: https://doi.org/10.1101/2020.11.10.20228361

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (241)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1426)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (586)
  • Epidemiology (10307)
  • Forensic Medicine (6)
  • Gastroenterology (528)
  • Genetic and Genomic Medicine (2637)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1740)
  • Health Policy (790)
  • Health Systems and Quality Improvement (676)
  • Hematology (268)
  • HIV/AIDS (568)
  • Infectious Diseases (except HIV/AIDS) (12103)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2466)
  • Nursing (145)
  • Nutrition (379)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1327)
  • Ophthalmology (403)
  • Orthopedics (147)
  • Otolaryngology (238)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2405)
  • Public and Global Health (5019)
  • Radiology and Imaging (895)
  • Rehabilitation Medicine and Physical Therapy (530)
  • Respiratory Medicine (682)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (246)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)